| ²é¿´: 574 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
¡¾ÌÖÂÛ¡¿ÄªÎ÷ɳÐÇÊäÒºµÄ¹æ¸ñ£¬¹úÍâÓÐ100mlÂð?
|
|||
¹úÄÚÅú×¼µÄ½ø¿ÚÑÎËáĪÎ÷ɳÐÇÂÈ»¯ÄÆ×¢ÉäÒºÊÇ250ml£º0.4gµÄ£¬ÏÖÔÚÀϰåÏëÒª¿ª·¢100mlµÄ£¬ÅóÓÑÃÇÖªµÀÔõô²é ¹úÍâ ÉÏÊеĹæ¸ñºÍÁãÊÛ¼Û°¡~~~ÄĸöÍøÕ¾¸üÈ«ÃæÒ»Ð©ÄØ, ÓÐÊ²Ã´ÍøÖ·¿ÉÒÔÁ´½ÓÒ»ÏÂÂð Íò·Ö¸Ðл¡£[ Last edited by ±×Ó329 on 2009-10-29 at 14:00 ] |
» ²ÂÄãϲ»¶
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ3È˻ظ´
ÄÔ¹£ÔõôÖÎÁÆ
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ167È˻ظ´
ÉúÎï×éÖ¯ÖÐÓÐÄ¿±ê·ÖÎöÎרÊôÐÔÔõô×ö
ÒѾÓÐ0È˻ظ´
±¿±¿Öí0608
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 1.643
- ½ð±Ò: 7585.2
- ºì»¨: 1
- Ìû×Ó: 3551
- ÔÚÏß: 47.1Сʱ
- ³æºÅ: 439613
- ×¢²á: 2007-10-16
- ÐÔ±ð: MM
- רҵ: ÖÐҩѧÆäËû¿ÆÑ§ÎÊÌâ
2Â¥2009-10-29 13:53:20
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
![]() ![]() ![]() FDA |
3Â¥2009-10-29 14:49:18
zmkj
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 3264.5
- É¢½ð: 1
- ºì»¨: 3
- Ìû×Ó: 340
- ÔÚÏß: 144.3Сʱ
- ³æºÅ: 855405
- ×¢²á: 2009-09-24
- רҵ: Ò©Îﻯѧ
ĪÎ÷ɳÐÇÊäÒºµÄ¹æ¸ñ£¬¹úÍâÓÐ100mlÂð
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
|
Ò©Æ·Ãû³Æ AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER ÉêÇëºÅ 021277 ²úÆ·ºÅ 001 »îÐÔ³É·Ö MOXIFLOXACIN HYDROCHLORIDE Êг¡×´Ì¬: ´¦·½Ò© ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; IV (INFUSION) ¹æ¸ñ 160MG/100ML ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ÊÇ Åú×¼ÈÕÆÚ 2001/11/30 ÉêÇë»ú¹¹ BAYER HEALTHCARE PHARMACEUTICALS INC »¯Ñ§ÀàÐÍ New formulation ÉóÆÀ·ÖÀà Standard review drug |
4Â¥2009-12-08 15:41:11














Íò·Ö¸Ðл¡£
»Ø¸´´ËÂ¥